People attending the clinic were being prescribed high numbers of medications but, given the prevalence of diabetes, heart failure and CKD, the use of SGLT2 inhibitors was relatively low and initiation of these drugs was the commonest medication change in the clinic. The gene discussed is SLC5A2; the disease is heart failure.